[THE PHYSIOLOGIC INHIBITORS OF BLOOD COAGULATION IN PATHOLOGICALLY INCREASED COAGULABILITY IN VIVO. II. SERUM INFUSION INTO THE BLOOD STREAM].
D000818:Animals; D000925:Anticoagulants; D000990:Antithrombin III; D000991:Antithrombins; D001769:Blood; D001777:Blood Coagulation; D001779:Blood Coagulation Factors; D001803:Blood Transfusion; D004791:Enzyme Inhibitors; D006493:Heparin; D010600:Pharmacology; D011817:Rabbits; D012106:Research; D012790:Shwartzman Phenomenon; D013917:Thrombin
D000925:Anticoagulants; D000991:Antithrombins; D001779:Blood Coagulation Factors; D004791:Enzyme Inhibitors; D000990:Antithrombin III; D006493:Heparin; D013917:Thrombin
ANTICOAGULANTS; ANTITHROMBIN; BLOOD; BLOOD COAGULATION FACTORS; BLOOD TRANSFUSION; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; HEPARIN; PHARMACOLOGY; RABBITS; SHWARTZMAN PHENOMENON; THROMBIN
DIE PHYSIOLOGISCHEN INHIBITOREN DER BLUTGERINNUNG BEI PATHOLOGISCH GESTEIGERTER GERINNBARKEIT IN VIVO. II. SERUMINFUSION IN DIE BLUTBAHN.